Alembic Pharmaceuticals Ltd
NSE:APLLTD

Watchlist Manager
Alembic Pharmaceuticals Ltd Logo
Alembic Pharmaceuticals Ltd
NSE:APLLTD
Watchlist
Price: 1 028 INR 0.83% Market Closed
Market Cap: 202.1B INR
Have any thoughts about
Alembic Pharmaceuticals Ltd?
Write Note

Alembic Pharmaceuticals Ltd
Cash from Investing Activities

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Alembic Pharmaceuticals Ltd
Cash from Investing Activities Peer Comparison

Comparables:
DRREDDY
CIPLA
SUNPHARMA
T
TORNTPHARM
M
MANKIND

Competitive Cash from Investing Activities Analysis
Latest Figures & CAGR of Competitors

Company Cash from Investing Activities CAGR 3Y CAGR 5Y CAGR 10Y
Alembic Pharmaceuticals Ltd
NSE:APLLTD
Cash from Investing Activities
-â‚ą3.2B
CAGR 3-Years
27%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Dr Reddy's Laboratories Ltd
NSE:DRREDDY
Cash from Investing Activities
-â‚ą40.3B
CAGR 3-Years
-21%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Cipla Ltd
NSE:CIPLA
Cash from Investing Activities
-â‚ą29.6B
CAGR 3-Years
-42%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Sun Pharmaceutical Industries Ltd
NSE:SUNPHARMA
Cash from Investing Activities
-â‚ą42.7B
CAGR 3-Years
-110%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
T
Torrent Pharmaceuticals Ltd
NSE:TORNTPHARM
Cash from Investing Activities
-â‚ą1.6B
CAGR 3-Years
-262%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
M
Mankind Pharma Ltd
NSE:MANKIND
Cash from Investing Activities
-â‚ą20.8B
CAGR 3-Years
-19%
CAGR 5-Years
N/A
CAGR 10-Years
N/A

See Also

What is Alembic Pharmaceuticals Ltd's Cash from Investing Activities?
Cash from Investing Activities
-3.2B INR

Based on the financial report for Jun 30, 2024, Alembic Pharmaceuticals Ltd's Cash from Investing Activities amounts to -3.2B INR.

What is Alembic Pharmaceuticals Ltd's Cash from Investing Activities growth rate?
Cash from Investing Activities CAGR 3Y
27%

Over the last year, the Cash from Investing Activities growth was 28%. The average annual Cash from Investing Activities growth rates for Alembic Pharmaceuticals Ltd have been 27% over the past three years .

Back to Top